We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 10,000 results
  1. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer

    Paclitaxel resistance is associated with a poor prognosis in non-small cell lung cancer (NSCLC) patients, and currently, there is no promising drug...

    Ling-bing Li, Ling-xiao Yang, ... **ao-gang Zhao in Acta Pharmacologica Sinica
    Article Open access 16 January 2024
  2. Xanthohumol hinders invasion and cell cycle progression in cancer cells through targeting MMP2, MMP9, FAK and P53 genes in three-dimensional breast and lung cancer cells culture

    Background

    Despite recent advances in the treatment of lung and breast cancer, the mortality with these two types of cancer is high. Xanthohumol (XN)...

    Zohreh Gholizadeh Siahmazgi, Shiva Irani, ... Vahid Haghpanah in Cancer Cell International
    Article Open access 02 August 2023
  3. Circ_CSPP1 Regulates the Development of Non-small Cell Lung Cancer via the miR-486-3p/BRD9 Axis

    In this study, we explored the role of circ_CSPP1 in non-small cell lung cancer (NSCLC) using NSCLC cell lines (A549 and H1299) and human bronchial...

    Dan **e, Shuyi Zhang, ... Hailin **ong in Biochemical Genetics
    Article 09 June 2022
  4. Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro

    Lung cancer is the second most prevalent type of cancer and is responsible for the highest number of cancer-related deaths worldwide. Non-small-cell...

    Bikash Manandhar, Keshav Raj Paudel, ... Kamal Dua in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 13 July 2023
  5. Inhibition of USP14 induces ER stress–mediated autophagy without apoptosis in lung cancer cell line A549

    Non-small cell lung cancer is the most common type of lung cancer, accounting for more than 80% of this tumor. Ubiquitin-specific protease (USP) 14...

    Ali-Asghar Moghadami, Elmira Aboutalebi Vand Beilankouhi, ... Saeed Nazari Soltan Ahmad in Cell Stress and Chaperones
    Article 06 July 2020
  6. Affinity of Mycobacterium tuberculosis strains for M059K microglial cells after migration through A549 alveolar epithelium

    Tuberculosis (TB) remains a major threat worldwide while central nervous system TB (CNS-TB) is one of the most severe forms of extrapulmonary TB....

    Article 09 April 2021
  7. Targeting pyruvate dehydrogenase kinase 1 overcomes EGFR C797S mutation-driven osimertinib resistance in non-small cell lung cancer

    Osimertinib, a selective third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), effectively targets the EGFR T790M...

    Wonyoung Park, Shibo Wei, ... Ki-Tae Ha in Experimental & Molecular Medicine
    Article Open access 01 May 2024
  8. Phenotypic Characteristics of Dormant Human Non-Small Cell Lung Cancer Cells Surviving Multifraction X-Ray Irradiation

    Phenotypic characteristics of human non-small cell lung cancer cells, A549 (p53 wild-type) and H1299 (p53-deficient) as well as their descendants...

    M. V. Pustovalova, E. I. Yashkina, ... S. V. Leonov in Bulletin of Experimental Biology and Medicine
    Article 28 November 2022
  9. Electrical cell-substrate impedance sensing (ECIS) as a tool to study microbial-cell interactions

    ECIS is an impedance-based method to study the cellular responses to a stimulus. Manipulating the alternating current frequencies in ECIS helped...

    S. Keerthi, A. Maya Nandkumar in In vitro models
    Article 09 August 2022
  10. Differential molecular alterations promoting non-small cell lung cancer under hypoxia

    Hypoxia is one of the hallmarks of the solid cancer microenvironment that dominates cancer progression and exacerbation. Under the oxygen-deprived...

    Lina M. Al-Najjar, Malek Zihlif, Yazun Jarrar in Genome Instability & Disease
    Article 21 March 2022
  11. Multi-omics sequencing revealed endostar combined with cisplatin treated non small cell lung cancer via anti-angiogenesis

    Background

    Endostar, an anti-angiogenic drug, has been approved for treating non-small cell lung cancer (NSCLC). At present, endostar combined with...

    Yufei Wang, Hong Ren in BMC Cancer
    Article Open access 08 February 2024
  12. Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture

    Lung cancer is the leading cause of cancer deaths globally with most of the reported cases (> 85%) associated with non-small cell lung cancer...

    Suyash M. Patil, Nitesh K. Kunda in Pharmaceutical Research
    Article 04 March 2022
  13. CircHSPB6 Promotes Tumor-Associated Macrophages M2 Polarization and Infiltration to Accelerate Cell Malignant Properties in Lung Adenocarcinoma by CCL2

    Circular RNAs (circRNAs) are reported to be involved in the tumorigenesis of lung adenocarcinoma (LUAD). Here, this study focused on studying the...

    Danqing Li, Fan Du, ... Shaofeng Zhang in Biochemical Genetics
    Article 23 August 2023
  14. APEX1 regulates alternative splicing of key tumorigenesis genes in non-small-cell lung cancer

    Background

    Aberrant alternative splicing (AS) contributes to tumor progression. Previous studies have shown that apurinic-apyrimidinic endonuclease-1...

    Li Peng, Yuwei Liu, ... Xujun Ye in BMC Medical Genomics
    Article Open access 02 July 2022
  15. Lung cancer cell-intrinsic IL-15 promotes cell migration and sensitizes murine lung tumors to anti-PD-L1 therapy

    Background

    IL-15 plays a vital role in enhancing NK cell- and T-cell-mediated antitumor immune responses; however, the direct effect of IL-15 on tumor...

    Shaojie Hu, Kelin Meng, ... Lequn Li in Biomarker Research
    Article Open access 19 April 2024
  16. DNMT1/miR-152-3p/SOS1 signaling axis promotes self-renewal and tumor growth of cancer stem-like cells derived from non-small cell lung cancer

    Background

    CSLCs(Cancer stem cell-like cells), which are central to tumorigenesis, are intrinsically influenced by epigenetic modifications. This...

    Qing Yuan, Rubo Wang, ... Jiansong Zhang in Clinical Epigenetics
    Article Open access 15 April 2024
  17. The world’s first digital cell twin in cancer electrophysiology: a digital revolution in cancer research?

    Background

    The introduction of functional in-silico models, in addition to in-vivo tumor models, opens up new and unlimited possibilities in cancer...

    Article Open access 11 October 2022
  18. The Expression of Non B Cell-Derived Immunoglobulins

    Although V(D)J recombination and immunoglobulin (Ig) production are traditionally recognised to occur only in B lymphocytes and plasma cells, the...
    Jie Zheng, Guohui Li, ... **aoJun Xu in Non B cell-Derived Immunoglobulins
    Chapter 2024
  19. HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism

    Background

    Histone deacetylases (HDAC) contribute to oncogenic program, pointing to their inhibitors as a potential strategy against cancers. We,...

    Jian Cui, Fei Xu, ... Wei Zuo in Journal of Translational Medicine
    Article Open access 15 February 2023
  20. Inhaled Indomethacin-Loaded Liposomes as Potential Therapeutics against Non-Small Cell Lung Cancer (NSCLC)

    Most lung cancer instances are non-small cell lung cancers (NSCLC). As stated by recent literature, cycloxygenase-2 (COX-2) is upregulated in lung...

    Sruthi Sarvepalli, Vineela Parvathaneni, ... Vivek Gupta in Pharmaceutical Research
    Article 15 September 2022
Did you find what you were looking for? Share feedback.